Form 4 for OCUL OCULAR THERAPEUTIX, INC

Accepted 2023-02-01 00:00:00 ET · period of report 2023-01-30 · accession 0001104659-23-009414 · SEC index · Original document

Summary rows

Aggregated the way they appear in lists: one row per insider, transaction code and security table.

X	Filed	Traded	Ticker	Insider	Title	Type	Price	Qty	Owned	ΔOwn	Value
D	2023-02-01	2023-01-30	OCUL	Ozden Rabia Gurses	Chief Medical Off	A - Grant	$0.00	+55.6K	107.8K	+106%	$0
DM	2023-02-01	2023-01-30	OCUL	Ozden Rabia Gurses	Chief Medical Off	A - Grant	$0.00	+216.7K	50.0K	New	$0

Purchase Sale Sale after option exercise All abbreviations

#	Table	Security	Date	Code	A/D	Shares	Price	Owned after	Own	Exercise / expiry	Underlying	Footnotes
1	Common	Common Stock	2023-01-30	A	A	55,556	$0.00	107,779	D	—	—	(F1) On January 30, 2023, the reporting person was granted restricted stock units ("RSUs") under the 2021 Stock Incentive Plan, as amended, of Ocular Therapeutix, Inc. (the "Company"). Each RSU represents a right to receive one share of the Company's common stock. Subject to the reporting person's continued service to the Company, the RSUs will vest over three years, with 1/3 of the shares underlying the RSUs vesting on the one-year anniversary of the date of grant and an additional 1/3 of the shares underlying the RSUs vesting at the end of each successive one-year period thereafter. (F2) Includes 62,223 shares of common stock of the Company underlying unvested RSUs.
2	Derivative	Stock Option (Right to Buy)	2023-01-30	A	A	166,667	$0.00	166,667	D	$3.88 · — to 2033-01-29	166,667 Common Stock	(F3) Vests over four years, vesting 1/48 monthly beginning on the one-month anniversary of the date of grant.
3	Derivative	Stock Option (Right to Buy)	2023-01-30	A	A	50,000	$0.00	50,000	D	$3.88 · — to 2033-01-29	50,000 Common Stock	(F4) Vests over two years, vesting 1/24 monthly beginning on the one-month anniversary of the date of grant.